Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial

Autor: Randon, Giovanni, Lonardi, Sara, Fassan, Matteo, Palermo, Federica, Tamberi, Stefano, Giommoni, Elisa, Ceccon, Carlotta, Di Donato, Samantha, Fornaro, Lorenzo, Brunetti, Oronzo, De Vita, Ferdinando, Bittoni, Alessandro, Chini, Claudio, Spallanzani, Andrea, Nappo, Floriana, Bethaz, Valerie, Strippoli, Antonia, Latiano, Tiziana, Cardellino, Giovanni Gerardo, Giuliani, Francesco, Morano, Federica, Niger, Monica, Raimondi, Alessandra, Prisciandaro, Michele, Pircher, Chiara Carlotta, Sciortino, Carolina, Marchesi, Silvia, Garattini, Silvio Ken, Airò, Giulia, Miceli, Rosalba, Di Bartolomeo, Maria, Pietrantonio, Filippo ^*

Publikováno v: In The Lancet Oncology December 2024 25(12):1539-1550

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population

Autor: Rimini, Margherita, Fornaro, Lorenzo, Rizzato, Mario Domenico, Antonuzzo, Lorenzo, Rossari, Federico, Satake, Tomoyuki, Vandeputte, Hanne, Vivaldi, Caterina, Pressiani, Tiziana, Lucchetti, Jessica, Kim, Jin Won, Abidoye, Oluseyi, Rapposelli, Ilario Giovanni, Tamberi, Stefano, Finkelmeier, Fabian, Giordano, Guido, Nichetti, Federico, Chon, Hong Jae, Braconi, Chiara, Pirrone, Chiara, Castet, Florian, Tamburini, Emiliano, Yoo, Changhoon, Parisi, Alessandro, Diana, Anna, Scartozzi, Mario, Prager, Gerald W., Avallone, Antonio, Schirripa, Marta, Kim, Il Hwan, Perkhofer, Lukas, Oneda, Ester, Verrico, Monica, Adeva, Jorge, Chan, Stephen L., Spinelli, Gian Paolo, Personeni, Nicola, Garajova, Ingrid, Rodriquenz, Maria Grazia, Leo, Silvana, Salani, Francesca, De Rosa, Antonio, Lavacchi, Daniele, Foti, Silvia, Ikeda, Masafumi, Dekervel, Jeroen, Niger, Monica, Balsano, Rita, Tonini, Giuseppe, Kang, Minsu, Bekaii-Saab, Tanios, Esposito, Luca, Boccaccino, Alessandra, Himmelsbach, Vera, Landriscina, Matteo, Djaballah, Selma Ahcene, Zanuso, Valentina, Masi, Gianluca, Lonardi, Sara, Rimassa, Lorenza, Casadei-Gardini, Andrea

Publikováno v: In European Journal of Cancer September 2024 208

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.

Autor: Niger, Monica¹ (AUTHOR) Monica.niger@istitutotumori.mi.it, Nichetti, Federico^1,2 (AUTHOR), Fornaro, Lorenzo³ (AUTHOR), Pircher, Chiara¹ (AUTHOR), Morano, Federica¹ (AUTHOR), Palermo, Federica¹ (AUTHOR), Rimassa, Lorenza^4,5 (AUTHOR), Pressiani, Tiziana⁵ (AUTHOR), Berardi, Rossana⁶ (AUTHOR), Gardini, Andrea Casadei^7,8 (AUTHOR), Sperti, Elisa⁹ (AUTHOR), Salvatore, Lisa^10,11 (AUTHOR), Melisi, Davide^12,13 (AUTHOR), Bergamo, Francesca¹⁴ (AUTHOR), Siena, Salvatore^15,16 (AUTHOR), Mosconi, Stefania¹⁷ (AUTHOR), Longarini, Raffaella¹⁸ (AUTHOR), Arcangeli, Giuseppina¹⁹ (AUTHOR), Corallo, Salvatore²⁰ (AUTHOR), Delliponti, Laura³ (AUTHOR)

Publikováno v: BMC Cancer. 4/8/2024, Vol. 24 Issue 1, p1-10. 10p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statement

Autor: Rimassa, Lorenza, Brandi, Giovanni, Niger, Monica, Normanno, Nicola, Melisi, Davide

Publikováno v: In Critical Reviews in Oncology / Hematology December 2023 192